Atlas Trials

Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer

Clinical trial NCT05463601 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05463601
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2022-08-01
Primary completion
2025-01-31
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.